Agency Forms Undergoing Paperwork Reduction Act Review, 32179-32180 [2019-14298]
Download as PDF
<![CDATA[
32179
Federal Register / Vol. 84, No. 129 / Friday, July 5, 2019 / Notices
be accomplished by standardizing and
enhancing sharing of existing ED data
locally collected by 52 health
departments (all 50 state health
departments, the health department of
Puerto Rico, and the health department
of the District of Columbia) with CDC.
In addition, CDC leadership
communicates with HHS on an ongoing
basis and this data is part of its request
to better monitor, plan and implement
programs to prevent overdose and
reduce subsequent harms.
DOSE proposes to fund 52 health
departments (50 state health
departments, the health department of
Puerto Rico and the health department
of the District of Columbia) to rapidly
share existing ED data on counts of ED
visits involving suspected drug, opioid,
heroin, and stimulant overdoses using
two standard data forms (i.e., the Rapid
ED overdose data form and the ED
discharge overdose data form) and
standard CDC case definitions.
The system will leverage ED
syndromic data and hospital discharge
data on ED visits already routinely
collected by state and territorial health
departments. No new data will be
systematically collected from EDs, and
health departments will be reimbursed
by CDC for the burden related to sharing
ED data with CDC. Fifty-two funded
health departments (50 state health
departments, Puerto Rico, and the
District of Columbia) will rapidly share
existing ED data with CDC on a monthly
basis using the Rapid ED overdose data
form and standard CDC case definitions.
Data may come from different local ED
data systems, but is expected to cover at
least 75% of ED visits in the jurisdiction
(e.g., state).
CDC will require all participating
health departments to provide counts of
ED visits involving suspected drug,
opioid, heroin, and stimulant overdoses
by county, age group, sex, and time (i.e.,
month and year) in a standardized
manner using the Rapid ED overdose
data form, which is an Excel data
template. This form also collects data
quality indicators such as percent of ED
visits missing data on key variables (i.e.,
metadata). In order to assess and
improve rapid ED data sharing, all 52
participating health departments will
also be asked to share counts of ED
visits involving suspected drug, opioid,
heroin and stimulant overdoses by
county, age group, sex, and time (i.e.,
month and year) from more finalized
hospital discharge files, the current
surveillance standard. The data will be
shared with CDC on a quarterly or
yearly basis using a standardized Excel
data form, the ED discharge overdose
data form, and standard CDC case
definitions. The total estimated annual
burden hours are 1,542. There are no
costs to the respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average
burden per
response
(hours)
Form name
State health departments, the DC health department and PR health department.
Jurisdictions sharing case-level ED data with
CDC through the NSSP BioSense (OMB
#0920–0824).
State health departments, the DC health department and PR health department.
State health departments, the DC health department and PR health department.
Rapid ED overdose data form .......................
28
12
3
Rapid ED overdose data form .......................
24
12
30/60
ED discharge overdose data form .................
26
4
3
ED discharge overdose data form—Year ......
26
1
3
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–14297 Filed 7–3–19; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–19–19MM]
Agency Forms Undergoing Paperwork
Reduction Act Review
jbell on DSK3GLQ082PROD with NOTICES
Number of
respondents
Type of respondent
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled Study on
Disparities in Distress Screening among
Lung and Ovarian Cancer to the Office
of Management and Budget (OMB) for
VerDate Sep<11>2014
17:54 Jul 03, 2019
Jkt 247001
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on March 6,
2019 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570 or
send an email to omb@cdc.gov. Direct
written comments and/or suggestions
regarding the items contained in this
notice to the Attention: CDC Desk
Officer, Office of Management and
Budget, 725 17th Street NW,
Washington, DC 20503 or by fax to (202)
E:\FR\FM\05JYN1.SGM
05JYN1
32180
Federal Register / Vol. 84, No. 129 / Friday, July 5, 2019 / Notices
395–5806. Provide written comments
within 30 days of notice publication.
Proposed Project
Study on Disparities in Distress
Screening among Lung and Ovarian
Cancer—New—National Center for
Chronic Disease Prevention and Health
Promotion (NCCDPHP) Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Within the cancer treatment
community, interest in the psychosocial
impacts of cancer diagnosis and
treatment is increasing. These
psychosocial impacts are wide ranging
and include not only anxiety related to
the illness and treatment side effects
such as pain, fatigue and cognition, but
also stress related to nonmedical issues
such as family relationships, financial
hardship, social stressors (e.g.
transportation), and stigmatization.
There is growing evidence that
addressing the psychosocial stresses of
cancer survivors increases both their
longevity and quality of life.
The 2016 Institute of Medicine
(currently, National Academies of
Sciences, Engineering, and Medicine)
ovarian cancer report, funded by CDC,
calls for increased study of the
psychosocial needs of ovarian cancer
survivors, recognizing the high rates of
depression, anxiety, and distress. Up to
60% of lung cancer survivors also
experience high levels of distress. Both
ovarian and lung cancer patients have
relatively low five-year survival rates
(45% and 17%, respectively). Therefore,
CDC believes that it is imperative to
develop a greater understanding about
the types of psychosocial services they
receive during their course of treatment
and follow-up care.
CDC proposes a new information
collection to examine the extent to
which disparities exist in distress
screening and follow-up among cancer
treatment facilities and programs across
the country. The study will include 50
healthcare facilities. From these
facilities, we will request existing
electronic health records (EHR) of 2,000
lung and ovarian cancer survivors. Data
elements collected will include patient
demographic information, cancer
diagnosis and treatment, experience
with distress screening and follow-up
care, and medical service utilization.
Patient names, addresses, birth dates
and Social Security Numbers will not be
collected.
Staff from twelve of the 50
participating healthcare facilities will be
invited to participate in an interview
and focus group to provide contextual
understanding about facilitators and
barriers to distress screening and followup processes. This is a one-time data
collection.
Results of this study will provide
CDC’s National Comprehensive Cancer
Control Program (NCCCP) with
information to assist with the
development of information, resources,
technical assistance, and future
evidence-based interventions to
improve the quality of life of lung and
ovarian cancer survivors. Summative
findings will be used to evaluate the
need to help with policy, systems, or
environmental changes that may
enhance the landscape of quality of life
services for cancer survivors in
communities at large. OMB approval is
requested for one year. The total
estimated annualized burden hours are
512.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Quantitative:
Healthcare Professionals (POC) .............
IT Staff .....................................................
Qualitative:
Healthcare Professionals .........................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2019–14298 Filed 7–3–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jbell on DSK3GLQ082PROD with NOTICES
[60Day–19–0639; Docket No. CDC–19–0052]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
VerDate Sep<11>2014
17:54 Jul 03, 2019
Jkt 247001
Number of
respondents
Instrument
Number of
responses per
respondent
Average
burden per
response
(in hours)
Survey ............................................................
EMR data .......................................................
50
50
1
1
20/60
7.5
Key Informant Interview .................................
Focus Groups .................................................
12
72
1
1
1
1.5
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Energy Employees Occupational
Illness Compensation Program Act of
2000 (EEOICPA) Special Exposure
Cohort Petitions. This information
collection project permits respondents
to submit petitions to HHS requesting
the addition of classes of employees to
the Special Exposure Cohort under
EEOICPA.
SUMMARY:
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
CDC must receive written
comments on or before September 3,
2019.
DATES:
You may submit comments,
identified by Docket No. CDC–2019–
0052 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
ADDRESSES:
E:\FR\FM\05JYN1.SGM
05JYN1
]]>Agencies
[Federal Register Volume 84, Number 129 (Friday, July 5, 2019)]
[Notices]
[Pages 32179-32180]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-14298]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-19-19MM]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled Study on Disparities in Distress Screening
among Lung and Ovarian Cancer to the Office of Management and Budget
(OMB) for review and approval. CDC previously published a ``Proposed
Data Collection Submitted for Public Comment and Recommendations''
notice on March 6, 2019 to obtain comments from the public and affected
agencies. CDC did not receive comments related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570 or send an email to [email protected]. Direct written comments
and/or suggestions regarding the items contained in this notice to the
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by fax to (202)
[[Page 32180]]
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Study on Disparities in Distress Screening among Lung and Ovarian
Cancer--New--National Center for Chronic Disease Prevention and Health
Promotion (NCCDPHP) Centers for Disease Control and Prevention (CDC).
Background and Brief Description
Within the cancer treatment community, interest in the psychosocial
impacts of cancer diagnosis and treatment is increasing. These
psychosocial impacts are wide ranging and include not only anxiety
related to the illness and treatment side effects such as pain, fatigue
and cognition, but also stress related to nonmedical issues such as
family relationships, financial hardship, social stressors (e.g.
transportation), and stigmatization. There is growing evidence that
addressing the psychosocial stresses of cancer survivors increases both
their longevity and quality of life.
The 2016 Institute of Medicine (currently, National Academies of
Sciences, Engineering, and Medicine) ovarian cancer report, funded by
CDC, calls for increased study of the psychosocial needs of ovarian
cancer survivors, recognizing the high rates of depression, anxiety,
and distress. Up to 60% of lung cancer survivors also experience high
levels of distress. Both ovarian and lung cancer patients have
relatively low five-year survival rates (45% and 17%, respectively).
Therefore, CDC believes that it is imperative to develop a greater
understanding about the types of psychosocial services they receive
during their course of treatment and follow-up care.
CDC proposes a new information collection to examine the extent to
which disparities exist in distress screening and follow-up among
cancer treatment facilities and programs across the country. The study
will include 50 healthcare facilities. From these facilities, we will
request existing electronic health records (EHR) of 2,000 lung and
ovarian cancer survivors. Data elements collected will include patient
demographic information, cancer diagnosis and treatment, experience
with distress screening and follow-up care, and medical service
utilization. Patient names, addresses, birth dates and Social Security
Numbers will not be collected.
Staff from twelve of the 50 participating healthcare facilities
will be invited to participate in an interview and focus group to
provide contextual understanding about facilitators and barriers to
distress screening and follow-up processes. This is a one-time data
collection.
Results of this study will provide CDC's National Comprehensive
Cancer Control Program (NCCCP) with information to assist with the
development of information, resources, technical assistance, and future
evidence-based interventions to improve the quality of life of lung and
ovarian cancer survivors. Summative findings will be used to evaluate
the need to help with policy, systems, or environmental changes that
may enhance the landscape of quality of life services for cancer
survivors in communities at large. OMB approval is requested for one
year. The total estimated annualized burden hours are 512.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondents Instrument respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Quantitative:
Healthcare Professionals (POC).... Survey.................. 50 1 20/60
IT Staff.......................... EMR data................ 50 1 7.5
Qualitative:
Healthcare Professionals.......... Key Informant Interview. 12 1 1
Focus Groups............ 72 1 1.5
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019-14298 Filed 7-3-19; 8:45 am]
BILLING CODE 4163-18-P
